Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
Article in Health Economics Review (February 2024)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
Article in Health Economics Review (February 2024)
Article in PharmacoEconomics (September 2021)
Article in Neurology and Therapy (July 2021)